Lifestyle Intervention Requirements for Novel Antiobesity Medications

This Viewpoint discusses how prerequisite comprehensive lifestyle interventions for novel antiobesity medications may disproportionately impact patients at highest risk of obesity-related complications and perpetuate disparities in care.

from JAMA Internal Medicine Online First https://ift.tt/TpAJz2r